These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32502990)

  • 21. Decreased psoas muscle area is a prognosticator for 90-day and 1-year survival in patients undergoing surgical treatment for spinal metastasis.
    Hu MH; Yen HK; Chen IH; Wu CH; Chen CW; Yang JJ; Wang ZY; Yen MH; Yang SH; Lin WH
    Clin Nutr; 2022 Mar; 41(3):620-629. PubMed ID: 35124469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases.
    Shi DD; Chen YH; Lam TC; Leonard D; Balboni TA; Schoenfeld A; Skamene S; Cagney DN; Chi JH; Cho CH; Harris M; Ferrone ML; Hertan LM
    Spine J; 2018 Jun; 18(6):935-940. PubMed ID: 29031992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of seven preoperative prognostic scoring systems for spinal metastases.
    Leithner A; Radl R; Gruber G; Hochegger M; Leithner K; Welkerling H; Rehak P; Windhager R
    Eur Spine J; 2008 Nov; 17(11):1488-95. PubMed ID: 18787846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which Scoring System Is the Most Accurate for Assessing Survival Prognosis in Patients Undergoing Surgery for Spinal Metastases from Lung Cancer? A Single-Center Experience.
    Tarabay B; Gennari A; Truong VT; Shen J; Dib R; Newmann N; Al-Shakfa F; Yuh SJ; Shedid D; Boubez G; Wang Z
    World Neurosurg; 2022 Dec; 168():e408-e417. PubMed ID: 36273732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
    Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
    Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma.
    Kumar N; Tan JJ; Zaw AS; Lim JL; Wai KL; Malhotra R; Loh TK; Liu GK; Thambiah J
    Spine J; 2014 Dec; 14(12):2946-53. PubMed ID: 24912121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SORG algorithm to predict 3- and 12-month survival in metastatic spinal disease: a cross-sectional population-based retrospective study.
    Zegarek G; Tessitore E; Chaboudez E; Nouri A; Schaller K; Gondar R
    Acta Neurochir (Wien); 2022 Oct; 164(10):2627-2635. PubMed ID: 35925406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of prognostic scoring systems for spinal metastases in 196 patients treated during 2005-2010.
    Dardic M; Wibmer C; Berghold A; Stadlmueller L; Froehlich EV; Leithner A
    Eur Spine J; 2015 Oct; 24(10):2133-41. PubMed ID: 25082760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy analysis of surgical treatment for spinal metastasis under the multidisciplinary team using the NOMS decision system combined with the revised Tokuhashi scoring system: a randomized controlled study.
    Xiang XB; Gao KY; Zhang WW; Li CP; Feng KK; Cao GR
    J Orthop Surg Res; 2024 Mar; 19(1):195. PubMed ID: 38515197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).
    Schoenfeld AJ; Le HV; Marjoua Y; Leonard DA; Belmont PJ; Bono CM; Harris MB
    Spine J; 2016 Apr; 16(4):482-90. PubMed ID: 26409416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of seven prognostic scores in patients with surgically treated epidural metastatic spine disease.
    Westermann L; Olivier AC; Samel C; Eysel P; Herren C; Sircar K; Zarghooni K
    Acta Neurochir (Wien); 2020 Jan; 162(1):109-119. PubMed ID: 31781995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tokuhashi score is predictive of survival in a cohort of patients undergoing surgery for renal cell carcinoma spinal metastases.
    Petteys RJ; Spitz SM; Rhee J; Goodwin CR; Zadnik PL; Sarabia-Estrada R; Groves ML; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL; Sciubba DM
    Eur Spine J; 2015 Oct; 24(10):2142-9. PubMed ID: 25772089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal Metastatic Disease: Survival Analysis of 146 Patients and Evaluation of 4 Different Preoperative Scoring Systems.
    Derincek A; Guler UO; Uysal M; Ozalay M
    Clin Spine Surg; 2020 Mar; 33(2):E81-E86. PubMed ID: 31393277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective evaluation of prognostic factors in metastatic spine disease: serum albumin and primary tumour type are key.
    Cook WH; Baker JF
    ANZ J Surg; 2020 Jun; 90(6):1070-1074. PubMed ID: 32175660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International external validation of the SORG machine learning algorithms for predicting 90-day and one-year survival of patients with spine metastases using a Taiwanese cohort.
    Yang JJ; Chen CW; Fourman MS; Bongers MER; Karhade AV; Groot OQ; Lin WH; Yen HK; Huang PH; Yang SH; Schwab JH; Hu MH
    Spine J; 2021 Oct; 21(10):1670-1678. PubMed ID: 33545371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.